grade
certified reference material
Quality Level
form
liquid
feature
(Snap-N-Spike®)
packaging
ampule of 1 mL
manufacturer/tradename
Cerilliant®
concentration
2.0 mg/mL in methanol
technique(s)
gas chromatography (GC): suitable, liquid chromatography (LC): suitable
application(s)
clinical testing
format
single component solution
storage temp.
−20°C
SMILES string
Fc1c(ncnc1)[C@@H]([C@](O)(C[n]3ncnc3)c2c(cc(cc2)F)F)C
InChI
1S/C16H14F3N5O/c1-10(15-14(19)5-20-7-22-15)16(25,6-24-9-21-8-23-24)12-3-2-11(17)4-13(12)18/h2-5,7-10,25H,6H2,1H3/t10-,16+/m0/s1
InChI key
BCEHBSKCWLPMDN-MGPLVRAMSA-N
General description
Voriconazole, sold under the trade name Vfend®, is a triazole antifungal drug prescribed for treatment of serious, invasive fungal infections. This certified Snap-N-Spike® Solution is suitable as starting material for linearity standards, calibrators, or controls for therapeutic drug monitoring or clinical and diagnostic testing of voriconazole in patient blood, serum, or plasma samples by HPLC or LC-MS/MS.
Legal Information
CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany
Vfend is a registered trademark of Pfizer, Inc.
signalword
Danger
Hazard Classifications
Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1
target_organs
Eyes,Central nervous system
存储类别
3 - Flammable liquids
wgk
WGK 2
flash_point_f
49.5 °F - closed cup
flash_point_c
9.7 °C - closed cup
法规信息
危险化学品
此项目有
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| V-032-1ML | 04061837428715 |